Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction CancersDigestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, brain disorder, carcinoma, central nervous system cancer, central nervous system disorder, digestive system disorder, digestive system neoplasm, epithelial neoplasm, esophageal adenocarcinoma, esophageal disorder, esophageal squamous cell carcinoma, gastric cardia adenocarcinoma, metastatic malignant neoplasm in the brain, neoplasm, neoplastic meningitis, nervous system disorder, squamous cell carcinoma, squamous cell neoplasm, tumor of meningesActive, not recruitingPhase 12026-07-31NCT04460937

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of Hope Comprehensive Cancer CenterDuarteUnited States263
Huntsman Cancer Institute/University of UtahSalt Lake CityUnited States249
Northwestern UniversityChicagoUnited States727
Ohio State University Comprehensive Cancer CenterColumbusUnited States548
University of Kentucky/Markey Cancer CenterLexingtonUnited States240
University of Utah Sugarhouse Health CenterSalt Lake CityUnited States52
UPMC Hillman Cancer CenterPittsburghUnited States330